Literature DB >> 16557874

Pathological changes in brain and other target organs of infant and weanling mice after infection with non-neuroadapted Western equine encephalitis virus.

M J Aguilar1.   

Abstract

Infant and weanling mice infected experimentally with non-neuroadapted Western equine encephalitis virus exhibited a differing spectrum of target-organ pathology as well as a different clinical response. The infant mice sickened and died within 48 hr. Pathological changes in this group were largely limited to such mesodermally derived tissues as muscle, cartilage, and bone marrow elements. The central nervous system was uninvolved, as were heart, lung, liver, and other body organs. The young adult mice, on the other hand, showed no clinical evidence of disease throughout the 376-hr postinfection period. Nevertheless, after 216 hr they developed acute diffuse meningoenceophalitis of the viral type, with concomitant changes in heart, lung, liver, kidney, and brown fat. The most striking and consistent finding in the infant group was acute necrotizing degeneration of the bone marrow. The most dramatic change in the young adult group was acute necrotizing meningoencephalitis.

Entities:  

Year:  1970        PMID: 16557874      PMCID: PMC416047          DOI: 10.1128/iai.2.5.533-542.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  An attenuated strain of Western equine encephalitis virus as a possible live immunizing agent.

Authors:  M Roca-Garcia; E L Jungherr; H N Johnson; H R Cox
Journal:  Proc Annu Meet U S Anim Health Assoc       Date:  1964

2.  The reaction of astrocytes to acute virus infections of the central nervous system.

Authors:  I Zlotnik
Journal:  Br J Exp Pathol       Date:  1968-12

3.  Perinatal arbovirus encephalitis and its sequelae.

Authors:  M J Aguilar; P R Calanchini; K H Finley
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1968

4.  Efficacy of an attenuated western encephalitis vaccine in equine animals.

Authors:  L N Binn; M L Sponseller; W L Wooding; S J McConnell; R O Spertzel; E H Yager
Journal:  Am J Vet Res       Date:  1966-11       Impact factor: 1.156

5.  Field strains of western encephalitis virus in ponies: virologic, clinical, and pathologic observations.

Authors:  M L Sponseller; L N Binn; W L Wooding; R H Yager
Journal:  Am J Vet Res       Date:  1966-11       Impact factor: 1.156

  5 in total
  12 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

2.  Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.

Authors:  Justin G Julander; Venkatraman Siddharthan; Lawrence M Blatt; Kristiina Schafer; Robert W Sidwell; John D Morrey
Journal:  Virology       Date:  2006-11-21       Impact factor: 3.616

3.  Subacute sclerosing encephalitis in adult hamsters infected with Langat virus.

Authors:  I Zlotnik; D P Grant; G B Carter; D Batter-Hatton
Journal:  Br J Exp Pathol       Date:  1973-02

4.  Discovery of anthranilamides as a novel class of inhibitors of neurotropic alphavirus replication.

Authors:  Scott J Barraza; Philip C Delekta; Janice A Sindac; Craig J Dobry; Jianming Xiang; Richard F Keep; David J Miller; Scott D Larsen
Journal:  Bioorg Med Chem       Date:  2015-02-11       Impact factor: 3.641

Review 5.  Arboviruses and the central nervous system.

Authors:  D E Griffin
Journal:  Springer Semin Immunopathol       Date:  1995

6.  Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model.

Authors:  Christopher H Logue; Christopher F Bosio; Thomas Welte; Kimberley M Keene; Jeremy P Ledermann; Aaron Phillips; Brian J Sheahan; Dennis J Pierro; Nicole Marlenee; Aaron C Brault; Catharine M Bosio; Amber J Singh; Ann M Powers; Ken E Olson
Journal:  J Gen Virol       Date:  2009-04-29       Impact factor: 3.891

7.  Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.

Authors:  Phillip C Delekta; Craig J Dobry; Janice A Sindac; Scott J Barraza; Pennelope K Blakely; Jianming Xiang; Paul D Kirchhoff; Richard F Keep; David N Irani; Scott D Larsen; David J Miller
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

8.  Effect of T-705 treatment on western equine encephalitis in a mouse model.

Authors:  Justin G Julander; Donald F Smee; John D Morrey; Yousuke Furuta
Journal:  Antiviral Res       Date:  2009-03-10       Impact factor: 5.970

9.  The pathogenesis of western equine encephalitis virus (W.E.E.) in adult hamsters with special reference to the long and short term effects on the C.N.S. of the attenuated clone 15 variant.

Authors:  I Zlotnik; S Peacock; D P Grant; D Batter-Hatton
Journal:  Br J Exp Pathol       Date:  1972-02

10.  Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection.

Authors:  Pennelope K Blakely; Bette K Kleinschmidt-DeMasters; Kenneth L Tyler; David N Irani
Journal:  J Neuropathol Exp Neurol       Date:  2009-10       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.